复星医药 · SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Last · —HK$17.15-0.07 (-0.41%)live · yahoo · 0s ago
Market capHK$45.8B2.12B sh
P/E · TTM12.0fwd — · eps 1.43
Beta—vs S&P 500
Div yield1.64%annual · TTM
52w range
HK$14.66HK$23.58
Volume1.8Msession
| Revenue | ¥51.7B |
|---|---|
| Operating income | ¥1.4B |
| Net income | ¥4.2B |
| Free cash flow | ¥57.2M |
| Operating margin | 2.7% |
| Net margin | 8.2% |
| Return on equity | 8.6% |
| Period | TTM 2026-03-31 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2025-03-26
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.92
Documents
FormReporting forFiledFlags